Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform

Yixi Chen, Shanlian Hu, Peng Dong, Åsa Kornfeld, Patrycja Jaros, Jing Yan, Fangfang Ma, Mondher Toumi

Open source

DOI
10.3402/jmahp.v4.30458
Published
2016-01
Container
Journal of Market Access & Health Policy
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3402/jmahp.v4.30458,
  title = {Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform},
  author = {Yixi Chen and Shanlian Hu and Peng Dong and Åsa Kornfeld and Patrycja Jaros and Jing Yan and Fangfang Ma and Mondher Toumi},
  year = {2016},
  journal = {Journal of Market Access \& Health Policy},
  doi = {10.3402/jmahp.v4.30458},
  url = {https://doi.org/10.3402/jmahp.v4.30458}
}

RIS

TY  - JOUR
TI  - Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform
AU  - Yixi Chen
AU  - Shanlian Hu
AU  - Peng Dong
AU  - Åsa Kornfeld
AU  - Patrycja Jaros
AU  - Jing Yan
AU  - Fangfang Ma
AU  - Mondher Toumi
PY  - 2016
JO  - Journal of Market Access & Health Policy
DO  - 10.3402/jmahp.v4.30458
UR  - https://doi.org/10.3402/jmahp.v4.30458
ER  - 

APA

Chen, Y., Hu, S., Dong, P., Kornfeld, Å., Jaros, P., Yan, J., Ma, F., & Toumi, M. (2016). Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform. Journal of Market Access & Health Policy. https://doi.org/10.3402/jmahp.v4.30458

Source records